[1]伍杨 白元 赵仙先.房间隔缺损与左心耳封堵一站式手术的研究进展[J].心血管病学进展,2022,(6):485.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.002]
　WU YangBAI YuanZHAO Xianxian.One-Stop Operation for Atrial Septal Defect and?eft Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2022,(6):485.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.002]
点击复制

房间隔缺损与左心耳封堵一站式手术的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年6期
页码:
485
栏目:
综述
出版日期:
2022-06-25

文章信息/Info

Title:
One-Stop Operation for Atrial Septal Defect and?eft Atrial Appendage Closure
作者:
伍杨 白元 赵仙先
(海军军医大学第一附属医院心血管内科,上海 200433)
Author(s):
WU YangBAI YuanZHAO Xianxian
?Department of Cardiology, The First Affiliated Hospital of Naval Medical University, Shanghai 200433,China)
关键词:
房间隔缺损; 左心耳封堵; 一站式
Keywords:
Atrial septal defect; Atrial fibrillation; Left atrial appendage closure; One-stop
DOI:
10.16806/j.cnki.issn.1004-3934.2022.06.002
摘要:
PROTECT-AF研究和PREVAIL研究证实左心耳封堵术在非瓣膜性患者中预防卒中效果不劣于华法林后，左心耳封堵术目前已成为患者预防卒中的一项重要手段，一些联合左心耳封堵术的一站式手术也在临床上广泛开展。而作为房间隔缺损的常见合并症，是否可以同期行房间隔缺损封堵术和左心耳封堵术，目前多个中心正在进行相关探索，综合目前的相关文献进行综述。
Abstract:
After the PROTECT-AF study and PREVAIL study confirmed that left atrial appendage closure is not inferior to warfarin in the prevention of stroke in patients with non-valvular atrial fibrillation, left atrial appendage closure has now become an important means of stroke prevention in patients with atrial fibrillation, and some "one-stop" operations combined with left atrial appendage closure have been widely carried out in clinic. Atrial fibrillation is a common complication of atrial septal defect, whether atrial septal defect occlusion and left atrial appendage closure can be performed at the same time, many centers are currently exploring, this article reviews the current relevant literature

参考文献/References:

[1] Boersma LV,Schmidt B,Betts TRet al. Implant success and safety of left atrial appendage closure with the WATCHMAN device:peri-procedural outcomes from the EWOLUTION registry[J]. Eur Heart J,2016,37(31):2465-2474.
[2] Holmes DR Jr,Reddy VY,Gordon NT,et al. Long-term safety and efficacy in continued access left atrial appendage closure registries[J]. J Am Coll Cardiol,2019,74(23):2878-2889.
[3] Osmancik P,Herman D,Neuzil P,et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation[J]. J Am Coll Cardiol,2020,75(25):3122-3135.
[4] Phillips KP,Pokushalov E,Romanov A,et al. Combining watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up[J]. Europace,2018,20(6):949-955.
[5] Mo BF,Sun J,Zhang PP,et al. Combined therapy of catheter ablation and left atrial appendage closure for patients with atrial fibrillation: a case-control study[J]. J Interv Cardiol,2020,2020:8615410.
[6] Fassini G,Gasperetti A,Italiano G,et al. Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure:a long-term follow-up analysis[J]. Heart Rhythm,2019,16(9):1320-1326.
[7] Wintgens L,Romanov A,Phillips K,et al. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry[J]. Europace,2018,20(11):1783-1789.
[8] Phillips KP,Romanov A,Artemenko S,et al. Combining left atrial appendage closure and catheter ablation for atrial fibrillation:2-year outcomes from a multinational registry[J]. Europace,2020,22(2):225-231.
[9] 姜小飞朱卫民李军,等. 经皮左心耳封堵联合冠状动脉介入"一站式"治疗对心动合并冠心病患者的安全性及疗效初探[J]. 中国心血管病研究2019,17(1):73-77.
[10] Zhang ZH,Yao Q,Huang HY,et al. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation[J]. BMC Cardiovasc Disord,2020,20(1):444.
[11] Leong MC,Kandavello G,Husin A,et al. Left atrial appendage and atrial septal occlusion in elderly patients with atrial septal defect and atrial fibrillation[J]. Pacing Clin Electrophysiol,2020,43(11):1252-1257.
[12] Drakopoulou M,Nashat H,Kempny A,et al. Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension[J]. Heart,2018,104(23):1963-1969.
[13] Teuwen CP,Ramdjan TT,G?tte M,et al. Time course of atrial fibrillation in patients with congenital heart defects[J]. Circ Arrhythm Electrophysiol,2015,8(5):1065-1072.
[14] Chiu SN,Wu MH,Tsai CT,et al. Atrial flutter/fibrillation in patients receiving transcatheter closure of atrial septal defect[J].J Formos Med Assoc,2017,116(7):522-528.
[15] Abrahamyan L,Dharma C,Alnasser S,et al. Long-term outcomes after atrial septal defect transcatheter closure by age and against population controls[J]. JACC Cardiovasc Interv,2021,14(5):566-575.
[16] Park KM,Hwang JK,Chun KJ,et al. Prediction of early-onset atrial tachyarrhythmia after successful trans-catheter device closure of atrial septal defect[J]. Medicine (Baltimore),2016,95(35):e4706.
[17] Fujii Y,Akagi T,Nakagawa K,et al. Clinical impact of transcatheter atrial septal defect closure on new onset atrial fibrillation in adult patients:comparison with surgical closure[J]. J Cardiol,2020,76(1):94-99.
[18] Yap SC. Atrial fibrillation and stroke after atrial septal defect closure. Is earlier closure warranted?[J]. Heart,2015,101(9):661-662.
[19] Waldmann V,Laredo M,Abadir S,et al. Atrial fibrillation in adults with congenital heart disease[J]. Int J Cardiol,2019,287:148-154.
[20] Moe TG,Abrich VA,Rhee EK. Atrial fibrillation in patients with congenital heart disease[J]. J Atr Fibrillation,2017,10(1):1612.
[21] Ebrahim MA,Escudero CA,Kantoch MJ,et al. Insights on atrial fibrillation in congenital heart disease[J]. Can J Cardiol,2018,34(11):1531-1533.
[22] Nakagawa K,Akagi T,Nagase S,et al. Efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with atrial septal defect:a comparison with transcatheter closure alone[J]. Europace,2019,21(11):1663-1669.
[23] Roberts-Thomson KC,John B,Worthley SG,et al. Left atrial remodeling in patients with atrial septal defects[J]. Heart Rhythm,2009,6(7):1000-1006.
[24] Nitta T,Sakamoto SI,Miyagi Y,et al. Reentrant and focal activations during atrial fibrillation in patients with atrial septal defect[J]. Ann Thorac Surg,2013,96(4):1266-1272.
[25] Starck CT,Steffel J,Emmert MY,et al. Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage[J]. Interact Cardiovasc Thorac Surg,2012,15(3):416-418.
[26] Nyboe C,Olsen MS,Nielsen-Kudsk JE,et al. Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure[J]. Heart,2015,101(9):706-711.
[27] Masuda K,Ishizu T,Niwa K,et al. Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias[J]. Int J Cardiol,2017,234:69-75.
[28] Mandalenakis Z,Rosengren A,Lappas G,et al. Ischemic stroke in children and young adults with congenital heart disease[J]. J Am Heart Assoc,2016,5(2):e003071.
[29] Engelfriet P,Boersma E,Oechslin E,et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease[J]. Eur Heart J,2005,26(21):2325-2333.
[30] Wang T,Chen L,Yang T,et al. Congenital heart disease and risk of cardiovascular disease: a meta-analysis of cohort studies[J]. J Am Heart Assoc,2019,8(10):e012030.
[31] Evertz R,Reinders M,Houck C,et al. Atrial fibrillation in patients with an atrial septal defect in a single centre cohort during a long clinical follow-up: its association with closure and outcome of therapy[J]. Open Heart,2020,7(2):e001298.
[32]王建铭,崔春生,盛晓棠同期行经皮左心耳封堵术与房间交通封堵术的临床研究[J]. 中国介入心脏病学杂志,2018,26(10):559-565.
[33]兰贝蒂,杜亚娟,张玉顺先心病联合左心耳一站式封堵治疗的效果及安全性评价[J]. 中国循证心血管医学杂志,2019,11(10):1236-1240.
[34] Glikson MWolff R,Hindricks G,et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion—an update[J]. EuroIntervention,2020,15(13):1133-1180.
[35] Kamioka M,Yoshihisa A,Hijioka N,et al. The efficacy of combination of transcatheter atrial septal defects closure and radiofrequency catheter ablation for the prevention of atrial fibrillation recurrence through bi-atrial reverse remodeling[J]. J Interv Card Electrophysiol,2020,59(2):365-372.
[36] Sang CH,Dong JZ,Long DY,et al. Transseptal puncture and catheter ablation of atrial fibrillation in patients with atrial septal occluder: initial experience of a single centre[J]. Europace,2018,20(9):1468-1474.
[37] Li B,Xie Z,Wang Q,et al. Biodegradable polymeric occluder for closure of atrial septal defect with interventional treatment of cardiovascular disease[J]. Biomaterials,2021,274:120851.
[38] Li Y,Xie Y,Li B,et al. Initial clinical experience with the biodegradable AbsnowTM device for percutaneous closure of atrial septal defect: a 3-year follow-up[J]. J Interv Cardiol,2021,2021:6369493.
[39] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J,2021,42(5): 373-498.

相似文献/References:

[1]于文波 陈振良 董向阳 陈忠建 崔亚洲 王鹏高 翟波.经食管超声引导三种不同路径封堵婴幼儿房间隔缺损的对比分析[J].心血管病学进展,2021,(9):849.[doi:10.16806/j.cnki.issn.1004-3934.20.09.000]
[2].LAmbreTM封堵器与新型口服抗凝药物预防心房颤动患者血栓栓塞事件的对照研究[J].心血管病学进展,2021,(11):1036.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
　LI YahuiWANG XuewenHUANG Congxin.A Comparative Study of LAmbreTM Device and Direct Oral Anticoagulants in Preventing Thromboembolic Events in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(6):1036.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
[3]李思聪 罗勤 赵智慧 赵青 柳志红.房间隔缺损相关肺动脉高压机制及治疗进展[J].心血管病学进展,2024,(1):11.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.004]
　LI Sicong,LUO Qin,ZHAO Zhihui,et al.Pathogenesis and Treatment of Pulmonary Hypertension Associated with Atrial Septal Defect[J].Advances in Cardiovascular Diseases,2024,(6):11.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.004]
[4]王健 刘美英 廖清池.房间隔缺损合并心房颤动的介入治疗进展[J].心血管病学进展,2019,(7):1028.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.016]
　WANG Jian,LIU Meiying,LIAO Qingchi.Interventional Therapy of Atrial Septal Defect with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(6):1028.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.016]

备注/Memo

备注/Memo:
?金项目：海军军医大学第一附属医院“234学科攀峰计划”（2020YXK010）
更新日期/Last Update: 2022-08-04